Terms: = Colorectal cancer AND C2orf44, FLJ21945, 80304, ENSG00000163026, PP384 AND Treatment
2 results:
1. Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial.
Ghidini M; Hochster H; Doi T; Van Cutsem E; Makris L; Takahashi O; Benhadji KA; Mansoor W
Gastric Cancer; 2023 Jul; 26(4):626-637. PubMed ID: 37106214
[TBL] [Abstract] [Full Text] [Related]
2. Oncogenic ALK Fusion in Rare and Aggressive Subtype of colorectal Adenocarcinoma as a Potential Therapeutic Target.
Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H
Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125
[TBL] [Abstract] [Full Text] [Related]
